Board of Directors

The Board of Directors, comprised of leading asthma experts, is GINA’s main governing body. It encourages dissemination and adoption of the reports on asthma management through utilization of existing health care structures in individual countries and promotes international collaboration on asthma research.

The GINA Board of Directors meets several times a year to discuss and plan programs and activities to carry out the goals of the GINA program.

 
Board of Directors
Disclosures

 

Guy Brusselle, MD, PhD, FERS, Chair
Ghent University
Ghent, Belgium

Ghent University Hospital
Ghent, Belgium

 

Keith Allan, CBiol, MRSB
Patient Partner
University Hospitals of Leicester
Leicester, United Kingsom

 

 

Muhwa Jeremiah Chakaya, MD
Kenyatta University
Nairobi, Kenya

Pulmonologist
Nairobi, Kenya

 

Alvaro A. Cruz, MD
Federal University of Bahia and Fundacao ProAR
Salvador, Brazil

Hospital Aliança - Rede D'Or
Salvador, Brazil

 

Hiromasa Inoue, MD
Kagoshima University
Kagoshima, Japan

Kagoshima University Hospital
Kagoshima, Japan

 

Jerry A. Krishnan, MD, PhD
Division of Pulmonary, Critical Care, Sleep, and Allergy
University of Illinois Hospital and Health Sciences System
Chicago, Illinois, USA

 

Mark L. Levy, MD
General Practitioner
London, United Kingdom

 

 

Helen K. Reddel, MBBS, PhD
Macquarie University and University of Sydney
Sydney, NSW, Australia

Sydney Local Health District
Sydney, NSW, Australia

 

Arzu Yorgancioglu, MD
Celal Bayar University Medical Faculty
Department of Pulmonary Diseases
Manisa, Turkey

Updated October 2025

GINA Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions:

  • Personal Benefits (Consultancy-Lecture Fees) refers to fees for lectures, advisory committees or consultancy services either intermittent or regular, from which a GINA member benefits personally. This includes ongoing attendance at advisory board meetings but would not normally include a situation where an individual is paid for a specific item or for attending or speaking at an occasional meeting.
  • Shares refers to any shares in the pharmaceutical industry, excluding unit trusts, pension plans or mutual funds, and it refers to shares held by a GINA member or family members (spouse/children). The company is to be listed, not the number of shares.
  • Non-Personal Interests refers to fees or grants paid to a GINA Committee member (or the Department/Institution on behalf of a GINA member) and used for research, education, equipment, salaries, etc.

View Board and Committee Annual Disclosures